LATRICA CONNER: Open Payments
NPI 1376812115 · HAMILTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,189 in 40 payments from 8 companies in 2025. Trend: 2023 $385 · 2024 $1,302 · 2025 $1,189
Food & beverage: $1,189
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $376 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $344 |
| Axsome Therapeutics, Inc. | 7 | $183 |
| Teva Pharmaceuticals USA, Inc. | 4 | $164 |
| ABBVIE INC. | 4 | $70 |
| Lundbeck LLC | 1 | $18 |
| Neos Therapeutics, LP | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
Products named: REXULTI, CAPLYTA, Auvelity, UZEDY, VRAYLAR, ABILIFY MAINTENA, AUSTEDO XR, Adzenys XR-ODT.
Industry payments across NJ — which companies pay providers there.
